Literature DB >> 1333754

Factors influencing the interaction of herpes simplex virus glycoprotein C with the third component of complement.

H P Huemer1, C Larcher, M P Dierich, D Falke.   

Abstract

The factors influencing the interaction of herpes simplex virus (HSV) glycoprotein C (gC) with the third component of complement (C3) were investigated in this study. The ability of gC of HSV type 1 (gC-1) to bind to the C3b fragment of C3 was found to be influenced by cell specific processing of gC-1 in a different manner, binding being remarkably enhanced in some cell lines following removal of sialic acid residues. Testing several intertypic recombinants of HSV we found that only strains expressing gC-1 exhibited binding to C3b, even though their genome consisted mainly of HSV-2 sequences in some recombinants. Expression of type-2 glycoproteins gB, gD, gE, gG, gH, and gI did not alter the ability of gC-1 to bind to C3b. Rosetting of HSV-1 infected Vero cells with C3b-coated red blood cells (EAC) was found to be temperature dependent and could be inhibited with purified C3b and anti-C3 antibodies. Polyanions like heparin or dextran sulfate were also inhibitory in a dose dependent manner, whereas C3d, neomycin and other aminoglycoside antibiotics failed to block. As the tested polyanions are also known to inhibit the infectivity of HSV, it could be speculated, that the complement binding function and the heparin-binding/attachment function of gC might be related.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333754     DOI: 10.1007/bf01309591

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  39 in total

1.  Evidence that neomycin inhibits binding of herpes simplex virus type 1 to the cellular receptor.

Authors:  N Langeland; H Holmsen; J R Lillehaug; L Haarr
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  Pathogenicity in mice of herpes simplex virus type 2 mutants unable to express glycoprotein C.

Authors:  D C Johnson; M R McDermott; C Chrisp; J C Glorioso
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

3.  Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2.

Authors:  R J Eisenberg; M Ponce de Leon; H M Friedman; L F Fries; M M Frank; J C Hastings; G H Cohen
Journal:  Microb Pathog       Date:  1987-12       Impact factor: 3.738

4.  Glycoprotein C-dependent attachment of herpes simplex virus to susceptible cells leading to productive infection.

Authors:  G Campadelli-Fiume; D Stirpe; A Boscaro; E Avitabile; L Foá-Tomasi; D Barker; B Roizman
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

5.  Comparison of heparin-sensitive attachment of pseudorabies virus (PRV) and herpes simplex virus type 1 and identification of heparin-binding PRV glycoproteins.

Authors:  D Sawitzky; H Hampl; K O Habermehl
Journal:  J Gen Virol       Date:  1990-05       Impact factor: 3.891

6.  Inhibitory effect of heparin on herpes simplex virus.

Authors:  A J Nahmias; S Kibrick
Journal:  J Bacteriol       Date:  1964-05       Impact factor: 3.490

7.  Properdin binds to sulfatide [Gal(3-SO4)beta 1-1 Cer] and has a sequence homology with other proteins that bind sulfated glycoconjugates.

Authors:  G D Holt; M K Pangburn; V Ginsburg
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

8.  The interaction of small oligomers of complement 3B (C3B) with phagocytes. High affinity binding and phorbol ester-induced internalization by polymorphonuclear leukocytes.

Authors:  E J Brown
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

9.  Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.

Authors:  T A McNearney; C Odell; V M Holers; P G Spear; J P Atkinson
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Pathogenicity of glycoprotein C negative mutants of herpes simplex virus type 1 for the mouse central nervous system.

Authors:  J C Sunstrum; C E Chrisp; M Levine; J C Glorioso
Journal:  Virus Res       Date:  1988-08       Impact factor: 3.303

View more
  4 in total

1.  The Integrated Genomic Landscape of Thymic Epithelial Tumors.

Authors:  Milan Radovich; Curtis R Pickering; Ina Felau; Gavin Ha; Hailei Zhang; Heejoon Jo; Katherine A Hoadley; Pavana Anur; Jiexin Zhang; Mike McLellan; Reanne Bowlby; Thomas Matthew; Ludmila Danilova; Apurva M Hegde; Jaegil Kim; Mark D M Leiserson; Geetika Sethi; Charles Lu; Michael Ryan; Xiaoping Su; Andrew D Cherniack; Gordon Robertson; Rehan Akbani; Paul Spellman; John N Weinstein; D Neil Hayes; Ben Raphael; Tara Lichtenberg; Kristen Leraas; Jean Claude Zenklusen; Junya Fujimoto; Cristovam Scapulatempo-Neto; Andre L Moreira; David Hwang; James Huang; Mirella Marino; Robert Korst; Giuseppe Giaccone; Yesim Gokmen-Polar; Sunil Badve; Arun Rajan; Philipp Ströbel; Nicolas Girard; Ming S Tsao; Alexander Marx; Anne S Tsao; Patrick J Loehrer
Journal:  Cancer Cell       Date:  2018-02-12       Impact factor: 31.743

2.  Species selective interaction of Alphaherpesvirinae with the "unspecific" immune system of the host.

Authors:  H P Huemer; C Larcher; S van Drunen Littel-van den Hurk; L A Babiuk
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.

Authors:  H P Huemer; Y Wang; P Garred; V Koistinen; S Oppermann
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

4.  Exploring First Interactions Between Ostreid Herpesvirus 1 (OsHV-1) and Its Host, Crassostrea gigas: Effects of Specific Antiviral Antibodies and Dextran Sulfate.

Authors:  Claire Martenot; Nicole Faury; Benjamin Morga; Lionel Degremont; Jean-Baptiste Lamy; Maryline Houssin; Tristan Renault
Journal:  Front Microbiol       Date:  2019-05-24       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.